Anesthetic Management of a Pediatric Patient with Arginase Deficiency

Arginase deficiency is an autosomal recessive disorder of the urea cycle in which a defect in conversion of arginine to urea and ornithine leads to hyperammonemia. Patients with urea cycle disorders may show increased protein catabolism due to inadequate intake of energy, protein and essential amino acids; infections, fever and surgery. A 12-year-old girl with arginase deficiency, ASA II who weighed 40 kg was scheduled for bilateral adductor, quadri-ceps and gastrocnemius tenotomies. She had mental retardation, spasticity and flexion posture of thelower limbs. Metabolic homeostasis was restored with appropriate diet. Successful anesthetic management allowed the patient to be discharged 48 hours after surgery. Increased levels of arginine and ammonia during or after surgery may lead to serious complications such as hypotension, cerebral edema, convulsions, hypothermia and spasticity. Thus special attention must be given to metabolic homeostasis and nutrition of the patients with arginase deficiency in the perioperative period. Primary goals should be to minimize stress levels by effective anxiolysis, provide an adequate amount of protein-free energy with proper fluid management and to obtain an effective preemptive and postoperative analgesia. In addition to a high level of knowledge, successful anesthesia requires professional communication among nursing staff, dietitians, pediatric metabolism specialist, surgeon and anesthesiologist.

Anahtar Kelimeler:

Arginase deficiency, spasticity surgery, anesthetic management

Anesthetic Management of a Pediatric Patient with Arginase Deficiency

Keywords:

Arginase deficiency, spasticity surgery, anesthetic management,

PDF

___

Scaglia F, Lee B. Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. Am J Med Genet C Semin Med Genet 2006;142:113-20. [CrossRef]
Brenton DP Inborn errors of amino acid and organic acid me- tabolism. In: Weatherall DJ, Ledingham JGG, Warrel DA, editors. Oxford Textbook of Medicine. 3rd ed. Vol. 2. Oxford: Oxford Medical Publications; 1996. p. 1352-88.
Prasad AN, Breen JC, Ampola MG, Rosman NP. Argininemia: a treatable genetic cause of progressive spastic diplegia simulating cerebral palsy: case reports and literature review. J Child Neurol 1997;12:301-9. [CrossRef]
Singh RH. Nutritional management of patients with urea cycle disorders. J Inherit Metab Dis 2007;30:880-7. [CrossRef]
Kaul N, Khan RM, Sharma PK, Sumant A. Anesthesia in a patient with arginase deficiency: implications and management. Pediat- ric Anesthesia 2008;18:1139-40. [CrossRef]
Cederbaum SD, Shaw KN, Spector EB, Verity MA, Snodgrass PJ, Sugarman GI. Hyperargininemia with arginase deficiency. Pediatr Res 1979;13:827-33. [CrossRef]
Brusilow SW, Horwich A Urea Cycle enzymes. In: Scriver CR, Be- audet AL, SlyWS, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. p. 1909-63.
Batshaw ML, MacArthur RB, Tuchman M. Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr 2001;138:46-54. [CrossRef]
Delwing D, Delwing de Lima D, Scolaro B, Kuss GG, Cruz JG, Wyse AT. Protective effect of antioxidants on cerebrum oxidative damage caused by arginine on pyruvate kinase activity. Metab Brain Dis 2009;24:469-74. [CrossRef]
Beal MF. Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 2000;23:298-304. [CrossRef] Scaglia F, Brunetti-Pierri N, Kleppe S, Marini J, Carter S, Garlick P, et al. Clinical consequences of urea cycle enzyme deficien- cies and potential links to arginine and nitric oxide metabolism. J Nutr 2004;134:2775-82.
Picker JD, Puga AC, Levy HL, Marsden D, Shih VE, Degirolami U, et al. Arginine deficiency with lethal neonatal expression: evi- dence for the glutamine hypothesis of cerebral edema. J Pediatr 2003;142:349-52. [CrossRef]